{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:37:06Z","timestamp":1780378626041,"version":"3.54.1"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1097\/qco.0000000000000058","type":"journal-article","created":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T16:41:50Z","timestamp":1396284110000},"page":"282-287","source":"Crossref","is-referenced-by-count":50,"title":["Preparing for an era of untreatable gonorrhea"],"prefix":"10.1097","volume":"27","author":[{"given":"Lindley A.","family":"Barbee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210205","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S1473-3099(13)70143-9","article-title":"Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011.","volume":"13","author":"Ison","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 4","key":"R2-11-20210205","doi-asserted-by":"crossref","first-page":"iv5","DOI":"10.1136\/sextrans-2013-051162","article-title":"Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: the Gonococcal Isolate Surveillance Project (GISP), January 2006-June 2012.","volume":"89","author":"Kirkcaldy","year":"2013","journal-title":"Sex Transm Infect"},{"key":"R3-11-20210205","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/OLQ.0b013e31827bd64c","article-title":"Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.","volume":"40","author":"Hottes","year":"2013","journal-title":"Sex Transm Dis"},{"issue":"Suppl 4","key":"R4-11-20210205","doi-asserted-by":"crossref","first-page":"iv28","DOI":"10.1136\/sextrans-2012-050904","article-title":"Monitoring antimicrobial resistance in Neisseria gonorrhoeae in selected countries of the WHO South-East Asia Region between 2009 and 2012: a retrospective analysis.","volume":"89","author":"Bala","year":"2013","journal-title":"Sex Transm Infect"},{"key":"R6-11-20210205","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2217\/fmb.12.117","article-title":"Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.","volume":"7","author":"Unemo","year":"2012","journal-title":"Future Microbiol"},{"key":"R7-11-20210205","doi-asserted-by":"crossref","first-page":"19721","DOI":"10.2807\/ese.15.47.19721-en","article-title":"Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010.","volume":"15","author":"Unemo","year":"2010","journal-title":"Euro Surveill"},{"key":"R8-11-20210205","doi-asserted-by":"crossref","first-page":"19833","DOI":"10.2807\/ese.16.14.19833-en","article-title":"Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.","volume":"16","author":"Ison","year":"2011","journal-title":"Euro Surveill"},{"key":"R9-11-20210205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2012.176575","article-title":"Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto Canada.","volume":"309","author":"Allen","year":"2013","journal-title":"JAMA"},{"key":"R10-11-20210205","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.","volume":"56","author":"Unemo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"R11-11-20210205","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1128\/AAC.00325-11","article-title":"Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea: detailed characterization of the first strain with high-level resistance to ceftriaxone.","volume":"55","author":"Ohnishi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"R12-11-20210205","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJMp1112456","article-title":"The emerging threat of untreatable gonococcal infection.","volume":"366","author":"Bolan","year":"2012","journal-title":"N Engl J Med"},{"key":"R13-11-20210205","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1258\/ijsa.2012.011378","article-title":"The value of testing multiple anatomic sites for gonorrhoea and chlamydia in sexually transmitted infection centres in the Netherlands, 2006-2010.","volume":"23","author":"Koedijk","year":"2012","journal-title":"Int J STD AIDS"},{"key":"R14-11-20210205","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/OLQ.0b013e3182495e2f","article-title":"Sentinel surveillance for pharyngeal chlamydia and gonorrhea among men who have sex with men - San Francisco, 2010.","volume":"39","author":"Park","year":"2012","journal-title":"Sex Transm Dis"},{"key":"R15-11-20210205","first-page":"397","article-title":"Are we missing pharyngeal and rectal infections in women by not testing those who report oral and anal sex Sex Transm I","volume":"89","author":"Shaw","year":"2013","journal-title":"nfect"},{"key":"R16-11-20210205","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/OLQ.0b013e31821890e9","article-title":"Screening of oropharynx and anorectum increases prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infection in female STD clinic visitors.","volume":"38","author":"Peters","year":"2011","journal-title":"Sex Transm Dis"},{"key":"R17-11-20210205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1086\/430704","article-title":"Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003.","volume":"41","author":"Kent","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R18-11-20210205","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1258\/ijsa.2008.008127","article-title":"Sexually transmitted infections among brothel-based sex workers in Tel-Aviv area, Israel: high prevalence of pharyngeal gonorrhoea.","volume":"19","author":"Linhart","year":"2008","journal-title":"Int J STD AIDS"},{"key":"R19-11-20210205","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/OLQ.0000000000000093","article-title":"Effect of nucleic acid amplification testing on detection of extra-genital gonorrhea and chlamydial infections in MSM STD clinic patients.","volume":"41","author":"Barbee","year":"2014","journal-title":"Sex Transm Dis"},{"key":"R20-11-20210205","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/OLQ.0b013e31822a2b2e","article-title":"Infections missed by urethral-only screening for chlamydia or gonorrhea detection among men who have sex with men.","volume":"38","author":"Marcus","year":"2011","journal-title":"Sex Transm Dis"},{"key":"R21-11-20210205","first-page":"1","article-title":"CDC CfDCaPSexually transmitted diseases treatment guidelines, 2010.","volume":"59","author":"Workowski","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"R23-11-20210205","first-page":"1798","article-title":"Pharyngeal gonorrhea: an important reservoir of infection Clin Infect D","volume":"49","author":"Weinstock","year":"2009","journal-title":"is"},{"key":"R24-11-20210205","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1128\/AAC.00505-12","article-title":"Management of pharyngeal gonorrhea is crucial to prevent the emergence and spread of antibiotic-resistant Neisseria gonorrhoeae.","volume":"56","author":"Deguchi","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"R25-11-20210205","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1128\/AAC.46.12.3744-3749.2002","article-title":"Mosaic-like structure of penicillin-binding protein 2 Gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime.","volume":"46","author":"Ameyama","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"R26-11-20210205","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1128\/AAC.49.1.137-143.2005","article-title":"Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in Central Japan.","volume":"49","author":"Ito","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"R27-11-20210205","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/clinids\/20.Supplement_1.S47","article-title":"Drugs of choice for the treatment of uncomplicated gonococcal infections.","volume":"20","author":"Moran","year":"1995","journal-title":"Clin Infect Dis"},{"key":"R28-11-20210205","first-page":"39","article-title":"Treating uncomplicated Neisseria gonorrhoeae infections: is the anatomic site of infection important Sex Transm D","volume":"22","author":"Moran","year":"1995","journal-title":"is"},{"key":"R29-11-20210205","first-page":"590","article-title":"Update to CDCs Sexually Transmitted Diseases Treatment Guidelines, 2010Oral cephalosporins no longer a recommended treatment for gonococcal infections.","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R30-11-20210205","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1258\/ijsa.2011.011267","article-title":"UK national guideline for the management of gonorrhoea in adults, 2011.","volume":"22","author":"Bignell","year":"2011","journal-title":"Int J STD AIDS"},{"key":"R31-11-20210205","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0956462412472837","article-title":"Board E.S.G.E.2012 European guideline on the diagnosis and treatment of gonorrhoea in adults.","volume":"24","author":"Bignell","year":"2013","journal-title":"Int J STD AIDS"},{"key":"R33-11-20210205","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1128\/AAC.20.6.839","article-title":"Dose-ranging study of ceftriaxone for uncomplicated gonorrhea in men.","volume":"20","author":"Handsfield","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"key":"R35-11-20210205","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1258\/ijsa.2009.009198","article-title":"Efficacy and safety of ceftriaxone for uncomplicated gonorrhoea: a meta-analysis of randomized controlled trials.","volume":"23","author":"Bai","year":"2012","journal-title":"Int J STD AIDS"},{"key":"R36-11-20210205","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/AAC.15.4.587","article-title":"Pharmacokinetic determinants of penicillin cure of gonococcal urethritis.","volume":"15","author":"Jaffe","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"R37-11-20210205","first-page":"2141","article-title":"Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink J Antimicrob C","volume":"65","author":"Chisholm","year":"2010","journal-title":"hemother"},{"key":"R38-11-20210205","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/QCO.0000000000000025","article-title":"Global resistance of Neisseria gonorrhoeae: when theory becomes reality.","volume":"27","author":"Lewis","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"R39-11-20210205","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/cid\/cit084","article-title":"A retrospective comparative study of two-drug oral and intramuscular cephalosporin treatment regimens for pharyngeal gonorrhea.","volume":"56","author":"Barbee","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R40-11-20210205","first-page":"647","article-title":"Pharyngeal gonorrhoea - is dual therapy the way forward Int J STD","volume":"18","author":"Sathia","year":"2007","journal-title":"AIDS"},{"key":"R41-11-20210205","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/OLQ.0000000000000033","article-title":"Retrospective review of pharyngeal gonorrhea treatment failures in Alberta Canada.","volume":"40","author":"Gratrix","year":"2013","journal-title":"Sex Transm Dis"},{"issue":"Suppl 4","key":"R42-11-20210205","doi-asserted-by":"crossref","first-page":"iv52","DOI":"10.1136\/sextrans-2012-050913","article-title":"Current and future treatment options for gonorrhoea.","volume":"89","author":"Ison","year":"2013","journal-title":"Sex Transm Infect"},{"key":"R43-11-20210205","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/OLQ.0b013e3181bf575c","article-title":"Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007.","volume":"37","author":"Brown","year":"2010","journal-title":"Sex Transm Dis"},{"key":"R44-11-20210205","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/postgradmedj-2012-050604rep","article-title":"Effectiveness of gentamicin for gonorrhoea treatment: systematic review and meta-analysis.","volume":"89","author":"Dowell","year":"2013","journal-title":"Postgrad Med J"},{"key":"R46-11-20210205","first-page":"3603","article-title":"In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea Antimicrob Agents C","volume":"56","author":"Unemo","year":"2012","journal-title":"hemother"},{"key":"R47-11-20210205","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s10156-013-0597-6","article-title":"In vitro activities of antimicrobial combinations against clinical isolates of Neisseria gonorrhoeae.","volume":"19","author":"Furuya","year":"2013","journal-title":"J Infect Chemother"},{"key":"R48-11-20210205","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/jac\/dks449","article-title":"Combination therapy for gonorrhoea: in vitro synergy testing.","volume":"68","author":"Pereira","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"R50-11-20210205","first-page":"2739","article-title":"In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatment option for gonorrhea Antimicrob Agents C","volume":"56","author":"Golparian","year":"2012","journal-title":"hemother"},{"key":"R52-11-20210205","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.1972.03210120051018","article-title":"CDC program for diagnosis of gonorrhea.","volume":"222","author":"Balows","year":"1972","journal-title":"JAMA"},{"key":"R53-11-20210205","first-page":"70","article-title":"How reliable is self-testing for gonorrhea and chlamydia among men who have sex with men J Fam P","volume":"62","author":"Sexton","year":"2013","journal-title":"ract"},{"key":"R54-11-20210205","doi-asserted-by":"crossref","first-page":"20444","DOI":"10.2807\/1560-7917.ES2013.18.14.20444","article-title":"Polymerase chain reaction-based screening for the ceftriaxone-resistant Neisseria gonorrhoeae F89 strain.","volume":"18","author":"Goire","year":"2013","journal-title":"Euro Surveill"},{"key":"R55-11-20210205","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa041681","article-title":"Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection.","volume":"352","author":"Golden","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Current Opinion in Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QCO.0000000000000058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:40:46Z","timestamp":1648730446000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001432-201406000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/qco.0000000000000058","relation":{},"ISSN":["0951-7375"],"issn-type":[{"value":"0951-7375","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}